Following primary infection, human cytomegalovirus (HCMV), establishes a life-long latent infection in the host. In contrast to knowledge of the cellular sites of lytic infection during active disease (Myerson et al., 1984; Sinzger et al., 1995; Wiley et al., 1986) , cellular sites of latency are poorly defined. Our previous in vivo studies identified monocytes as a major site of persistence in normal virus carriers (TaylorWiedeman et al., 1991) . Subsequent studies showed no evidence of endogenous HCMV lytic gene expression in monocytes, although immediate early (IE) gene expression could be induced on differentiation of these cells to monocytederived macrophages (MDM) (Taylor-Wiedeman et al., 1994) . These results are consistent with in vitro studies demonstrating that HCMV lyric gene expression was dependent on the differentiation state of the cell (Gonczol et al., 1984; Shelboum et al., 1989; Sinclair et al., 1992) . Monocytes only circulate in the peripheral blood for 1-3 days and HCMV cannot be reproducibly isolated from the peripheral blood of healthy virus carriers. In addition, monocytes are unable to be efficiently infected with HCMV in vitro (Einhorn & Ost, 1984) . It is therefore difficult to postulate that the carriage of virus by Author for correspondence: John Sinclair. Fax +44 1223 336846. e-mail js@mole.bio.cam.ac.uk monocytes results from direct primary infection. We have previously suggested that HCMV infects myeloid cells earlier in their lineage, as bone marrow progenitors , a hypothesis supported by experiments showing that bone marrow progenitors could be infected by HCMV in vitro and, with the exception of one report (Maciejewski et al., 1992) , could carry the virus in the absence of lytic virus gene expression (Kondo et aL, 1994; Minton et aL, 1994) . In addition, monocytes grown out from bone marrow mononuclear cells (BMMC) in long-term culture were shown to carry HCMV DNA, implying that HCMV was present in bone marrow progenitors (Minton et al., 1994) . However, to date, endogenous HCMV DNA has not been directly demonstrated in bone marrow progenitors. This work describes the isolation of pure populations of peripheral blood monocytes from normal virus carriers by fluorescence-activated cell sorting (FACS) and confirms the presence of HCMV DNA in these cells. Furthermore, we have isolated bone marrow progenitors carrying the CD34 antigen on their cell surface, a marker which is lost early in bone marrow cell differentiation, and have determined whether endogenous HCMV DNA and RNA is present in these cells.
Venous blood (60 ml) was venesected from six healthy laboratory volunteers, five of whom were seropositive and one seronegative by ELISA (CAPTIA CMV-TIA; Mercia Diagnostics). Blood was diluted 1:2 with sterile PBS (Sigma) and layered onto Ficoll-Hypaque gradients (Lymphoprep; Nycomed). Peripheral blood mononuclear cells (PBMC) were obtained by centrifugation at 2000 r.p.m, for 30 rain without brake on deceleration, washed twice in sterile PBS and stained with directly FITC-conjugated antibody to CD14 (Sigma), specific for monocytes in peripheral blood. CDI4 + and CDI4-cells were sorted using a FACS Vantage cell sorter (Becton Dickinson), CD14 + purity ranging from 97-99%. DNA was isolated from both populations using a modified sodium perchlorate technique (Taylor-Wiedeman et al., 1991) .
CD14 + or CD14-cell DNA (1 ~g) was amplified using nested PCR targeting exon 4 of the major IE region of HCMV as previously described 199I) . The amplified product after a total of 65 cycles was a 293 bp fragment. In duplicate experiments, IE-1 exon 4 PCR was positive in CD14+-sorted populations from 3/5 seropositive subjects, confirming the presence of HCMV DNA in these cells ,09 c. 0001-4112 © 1996 SGM ( Fig. Ia) . CD14 + cell populations from 2/5 seropositive and the one seronegative subject were PCR-negative, in addition to all CD14-cell populations. As a positive control for PCR amplification, p-globin gent PCR was performed on DNA from the same cells ( Fig. 1 b) .
Having confirmed the presence of HCMV DNA in CD14 + cell populations, we isolated pure populations of CD34 + bone marrow progenitors to determine whether HCMV DNA and RNA were present. Human bone marrow was obtained from eight subjects undergoing routine total hip replacement along with venous blood for serotesting (five seropositive, three seronegative). Bone marrow was diluted 1 : 4 in sterile PBS and layered onto Ficoll-Hypaque gradients. BMMC were extracted following centrifugation at 2000 r.p.m, for 30 min without brake on deceleration, washed twice in PBS and stained with directly FITC-conjugated antibody to CD34 (Becton Dickinson). The resulting yield of CD34 + populations ranged from 9 x 10 ~-2 x 106 cells and in purity from 95-99 % for seropositive and 92-99 % for seronegative subjects. D N A was isolated as described above and total RNA was isolated from four of the subjects' CD34 + populations using an RNA extraction kit (Promega) based on the method of Chomczynski & Sacchi (1987) . CD34 + cell D N A (I lag) was amplified using the IE-I PCR described above. PCR products were Southern blotted and 247 bp (Sambrook et al., 1989) . In duplicate experiments, PCR gave a positive band at 293 bp with a corresponding positive signal on the Southern blot for all five of the seropositive subjects (Fig. 2a) . Two out of three seronegative subjects were PCR-negative although one gave a reproducibly weak positive band at 293 bp despite stringent negative controls, which were all negative. This phenomenon of PCR-positive, seronegative individuals has been previously documented although, to date, its relevance to latency and reactivation is undetermined (Stanier et al., 1989; TaylorWiedeman et al., 1991) . DNA from all eight subjects gave a positive result for the fl-globin gene PCR (Fig. 2 b) . In order to control for the potential presence of HCMV-containing CD14 + cell contamination of our CD34 + populations, representative aliquots of CD34 + sorted cells were stained with directly phycoerythrin-conjugated CD14 antibody (Sigma) and analysed by flow cytometry. Between 0"6-1% of cells from the CD34 + populations stained with anti-CD14 antibody. This level of contamination by potential HCMV-containing monocytes is not great enough to account for the positive PCR signal seen in our experiments, as previous experience has shown that a minimum of I lag of To determine whether CD34 + cell populations carrying HCMV DNA expressed lyric cycle genes, total RNA from 10 ~ CD34 + cells was reverse-transcribed using a one-step oligo(dt)-primed kit (Pharmacia). cDNA was amplified using a nested IE-I intron-spanning PCR (100 cycles total) as previously described (Taylor-Wiedeman eta] ., 1994). The sensitivity of this coupled RT-PCR was one copy of in vitro-transcribed IE-1 mRNA produced by in vitro transcription of pGEM IE-1 cDNA, in the presence of I p.g of HCMV-seronegative PBMC total RNA (Fig. 3 a) . In duplicate experiments using RNA from two seropositive/PCR-positive and two seronegative/PCRnegative subjects, we found no evidence of HCMV major IE gene expression (Fig. 3b) . In addition, no lyric IE gene transcription was present in CD34 + populations from five further seropositive individuals for whom HCMV DNA PCR was not performed (data not shown). To ensure our negative results were not due to a general inability to detect the mRNA in the samples by RT-PCR, amplifications of the intronspanning histidyl t-RNA synthetase gene were performed and in each case yielded a positive band at 128 bp corresponding to amplified cDNA (Fig. 3 c) .
Our results demonstrate that HCMV DNA is present in pure CD14 + monocytes, extending our previous findings which predominantly used adherent PBMC (Taylor-Wiedeman et al., 1991) . In addition, we have shown that no virus DNA can be detected in CD14-populations in vivo, a population representing mainly lymphocytes, a site previously implicated in latency (Einhom & Ost, 1984; Rice et al., 1985 ; Schrier et al., 1985) . We have proceeded to demonstrate the presence of endogenous HCMV DNA in CD34 + bone marrow progenitors from normal virus carriers in vivo, which cannot be due to contamination by monocytes. We are aware that, apart from bone marrow progenitors, CD34 antigen is also expressed by endothelial cells, a cell type infected by HCMV during active disease in vivo. Using an endothelium-specific monoclonal antibody (EN-4, Harlan-Seralab) and an indirect immunofluorescence assay, we found no evidence of contamination by endothelial cells in our pure sorted populations of CD34 + progenitors (data not shown). Interestingly, Van Laer et al. (1995) have recently been unable to demonstrate HCMV DNA in CD34 + populations from healthy bone marrow donors by PCR using DNA template from 105 cells. This may be explained in part by the small numbers of cells used to isolate DNA and also by different DNA extraction and PCR protocols. It is clear that the frequency of HCMV-infected cells in peripheral blood is extremely low (probably less than 1 in 10000 PBMC) and therefore differences in sensitivity of PCR caused by different techniques may be the reason that HCMV is not consistently detectable in peripheral blood or bone marrow.
In addition to our PCR results, we have found no evidence of lyric HCMV major IE gene expression in CD34 + cells by RT-PCR. Kondo et al. (1994) recently demonstrated the presence of predominantly unspliced antisense IE-1 transcripts in cells co-expressing CD33, CD15 and CD14 antigens, obtained by in vitro infection of human fetal liver or bone marrow cells with the lacZ derivative of HCMV strain Towne RC256 or low passage isolate Toledo and subsequent propagation in suspension culture in the absence of virus production. These transcripts were estimated to be present in no less than 2-5 % of these in vitro-infected cells. Interestingly, endogenous novel sense and antisense transcripts from the same major IE region have also been found in healthy carriers (Kondo & Mocarski, 1995) . Co-expression of CD33, CD15 and CD14 first occurs during monocyte development on the cell surface of bone marrow monoblasts, cells which are already committed to the monocyte-macrophage lineage. Although in the experiments of Kondo and coworkers a small number of cells used to initiate the cell cultures expressed CD34 antigen, at the time of sampling for RT-PCR the cells were uniformly CD34-. The cells studied in our experiments represent a more primitive non-committed population, distinct from the committed cells studied by Kondo and coworkers. An alternative explanation may be that our methods and those used by Kondo and coworkers for analysing IE gene transcripts were not comparable, and that our inability to detect their latent transcripts was due to suboptimum sensitivity. To address this ( question, we have analysed unsorted BMMC and sorted CD34 + populations from further seropositive and seronegative individuals, using identical methods to those used by Kondo and coworkers (Kondo et aI., I994; Kondo & Mocarski, 1995) , and have been unable to detect any sense or antisense HCMV major IE transcripts despite the ability to detect endogenous cel|u[ar RNA from the histidy[ t-RNA synthetase gene by this RT-PCR protocol (data not shown). However, we have not yet determined the sensitivity of the PCRs used to identify latent transcripts, which may be the critical factor determining detection.
In summary, we have confirmed that CD14 + monocytes are a site of persistence of HCMV DNA and have shown that CD34 + bone marrow progenitors carry endogenous HCMV DNA in vivo. Furthermore, we have been unable to detect any evidence of HCMV lytic gene expression in these cells. These findings are consistent with the hypothesis that HCMV infects bone marrow progenitors and persists through monocytemacrophage ceil lineage differentiation and division in the absence of lyric gene expression, by an as yet unknown mechanism.
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